Since the most commonly reported ocular AE was presence of medication in the anterior chamber, we optimized the manufacturing process for GB-102 to enhance its binding affinity thus improving its ability to aggregate post injection
Adult Obesity Facts, CDC Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial, Obesity (2020) Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity, The New England Journal of Medicine (2023) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects, Frontiers in Endocrinology (2021) Wegovy: Understanding list price, NovoCare How much should I expect to pay for Mounjaro?, Lilly (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
PubMed, Weidinger, Stephan, et al
Salcaprozate Sodium (SNAC) 5 mg
Eligibility for Zepbound typically includes having a BMI of at least 30, or a BMI over 27 accompanied by related health conditions like high blood pressure, heart disease, type 2 diabetes, high cholesterol, or sleep apnea